Show simple item record

AB0340 MULTI-DRUG RESISTANT RA IS ASSOCIATED WITH HIGHER BASELINE DISEASE ACTIVITY, MULTI-MORBIDITY, AND LOWER QUALITY OF LIFE: ANALYSES FROM THE R4RA BIOPSY-DRIVEN CLINICAL TRIAL

dc.contributor.authorRivellese, F
dc.contributor.authorCurrado, D
dc.contributor.authorGiorli, G
dc.contributor.authorPrediletto, E
dc.contributor.authorNerviani, A
dc.contributor.authorKhmelevskaya, A
dc.contributor.authorMicheroli, R
dc.contributor.authorOspelt, C
dc.contributor.authorLewis, M
dc.contributor.authorBombardieri, M
dc.contributor.authorPitzalis, C
dc.date.accessioned2023-12-05T09:22:15Z
dc.date.available2023-12-05T09:22:15Z
dc.date.issued2023-06
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/92604
dc.format.extent1353 - 1354
dc.publisherBMJen_US
dc.subject3 Good Health and Well Beingen_US
dc.titleAB0340 MULTI-DRUG RESISTANT RA IS ASSOCIATED WITH HIGHER BASELINE DISEASE ACTIVITY, MULTI-MORBIDITY, AND LOWER QUALITY OF LIFE: ANALYSES FROM THE R4RA BIOPSY-DRIVEN CLINICAL TRIALen_US
dc.typeArticleen_US
dc.identifier.doi10.1136/annrheumdis-2023-eular.750
pubs.notesNot knownen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record